Colin Pawlowski

1.7k citations

30 papers · 857 indexed · h-index 16

Co-authors: Dimitris Bertsimas Ying Daisy Zhuo John C. O’Horo Andrew D. Badley Venky Soundararajan AJ Venkatakrishnan Arjun Puranik Patrick J. Lenehan
Topics: SARS-CoV-2 and COVID-19 Research (15 papers)COVID-19 Clinical Research Studies (13 papers)Vaccine Coverage and Hesitancy (7 papers)
Cited by: Infectious Diseases Health Modeling and Simulation
Journals: Circulation Journal of Clinical Investigation Journal of Clinical Oncology
Partner nations: United States Netherlands Italy

In The Last Decade

Colin Pawlowski

29 papers receiving 828 citations

Peers

Countries citing papers authored by Colin Pawlowski

Since Specialization

Citations

This map shows the geographic impact of Colin Pawlowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin Pawlowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin Pawlowski more than expected).

Fields of papers citing papers by Colin Pawlowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin Pawlowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin Pawlowski. The network helps show where Colin Pawlowski may publish in the future.

Co-authorship network of co-authors of Colin Pawlowski

This figure shows the co-authorship network connecting the top 25 collaborators of Colin Pawlowski. A scholar is included among the top collaborators of Colin Pawlowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin Pawlowski. Colin Pawlowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Case-control study on post-COVID-19 conditions reveals severe acute infection and chronic pulmonary disease as potential risk factors 2024 ·iScience ·Pritha Ghosh,Michiel J.M. Niesen,Colin Pawlowski,(unknown),(unknown),Patrick J. Lenehan,Praveen Kumar,(unknown),Jason Ross,(unknown),John C. O’Horo,AJ Venkatakrishnan,Clifford J. Rosen,Amalio Telenti,Ryan T. Hurt,Venky Soundararajan	1
2	Tensor completion with noisy side information 2023 ·Machine Learning ·Dimitris Bertsimas,Colin Pawlowski	1
3	Expanding repertoire of SARS-CoV-2 deletion mutations contributes to evolution of highly transmissible variants 2023 ·Scientific Reports ·AJ Venkatakrishnan,Praveen Anand,Patrick J. Lenehan,Pritha Ghosh,(unknown),Eli Silvert,Colin Pawlowski,(unknown),(unknown),John C. O’Horo,Joseph D. Yao,Bobbi S. Pritt,Andrew P. Norgan,Ryan T. Hurt,Andrew D. Badley,John Halamka,Venky Soundararajan	3
4	Durability analysis of the highly effective BNT162b2 vaccine against COVID-19 2022 ·PNAS Nexus ·Arjun Puranik,Patrick J. Lenehan,John C. O’Horo,Colin Pawlowski,Michiel J.M. Niesen,Abinash Virk,Melanie D. Swift,Walter K. Kremers,AJ Venkatakrishnan,(unknown),Holly L. Geyer,Leigh L. Speicher,Venky Soundararajan,Andrew D. Badley	8
5	SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes 2022 ·PNAS Nexus ·Colin Pawlowski,Eli Silvert,John C. O’Horo,Patrick J. Lenehan,Douglas W. Challener,(unknown),(unknown),Jason Ross,Leigh L. Speicher,Holly L. Geyer,(unknown),Andrew D. Badley,Venky Soundararajan	11
6	Third dose vaccination with mRNA-1273 or BNT162b2 vaccines improves protection against SARS-CoV-2 infection 2022 ·PNAS Nexus ·Michiel J.M. Niesen,(unknown),Arjun Puranik,John C. O’Horo,Colin Pawlowski,(unknown),Douglas W. Challener,Abinash Virk,Melanie D. Swift,Leigh L. Speicher,(unknown),Holly L. Geyer,Patrick J. Lenehan,AJ Venkatakrishnan,Venky Soundararajan,Andrew D. Badley	7
7	Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19 2021 ·EClinicalMedicine ·Raymund R. Razonable,Colin Pawlowski,John C. O’Horo,Lori L. Arndt,Richard Arndt,Dennis M. Bierle,(unknown),Sara N. Hanson,(unknown),Patrick J. Lenehan,Arjun Puranik,Maria Teresa Seville,Leigh L. Speicher,Sidna M. Tulledge‐Scheitel,AJ Venkatakrishnan,Caroline G. Wilker,Andrew D. Badley,Ravindra Ganesh	97
8	Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19 2021 ·Journal of Clinical Investigation ·Ravindra Ganesh,Colin Pawlowski,John C. O’Horo,Lori L. Arndt,Richard Arndt,Sarah Bell,Dennis M. Bierle,(unknown),Sara N. Hanson,(unknown),Jennifer J. Larsen,Patrick J. Lenehan,Robert Orenstein,Arjun Puranik,Leigh L. Speicher,Sidna M. Tulledge‐Scheitel,AJ Venkatakrishnan,Caroline G. Wilker,Andrew D. Badley,Raymund R. Razonable	36
9	FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system 2021 ·Med ·Colin Pawlowski,Patrick J. Lenehan,Arjun Puranik,(unknown),AJ Venkatakrishnan,Michiel J.M. Niesen,John C. O’Horo,Abinash Virk,Melanie D. Swift,Andrew D. Badley,John Halamka,Venky Soundararajan	112
10	Exploratory analysis of immunization records highlights decreased SARS-CoV-2 rates in individuals with recent non-COVID-19 vaccinations 2021 ·Scientific Reports ·Colin Pawlowski,Arjun Puranik,(unknown),AJ Venkatakrishnan,(unknown),Richard B. Kennedy,John C. O’Horo,Gregory J. Gores,Amy W. Williams,John Halamka,Andrew D. Badley,Venky Soundararajan	79
11	Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System 2021 ·Journal of Stroke and Cerebrovascular Diseases ·Colin Pawlowski,(unknown),Samir Awasthi,(unknown),Patrick J. Lenehan,AJ Venkatakrishnan,Sairam Bade,John C. O’Horo,Abinash Virk,Melanie D. Swift,Amy W. Williams,Gregory J. Gores,Andrew D. Badley,John Halamka,Venky Soundararajan	29
12	Enoxaparin is associated with lower rates of mortality than unfractionated Heparin in hospitalized COVID-19 patients 2021 ·EClinicalMedicine ·Colin Pawlowski,AJ Venkatakrishnan,(unknown),(unknown),Arjun Puranik,John C. O’Horo,Andrew D. Badley,Venky Soundararajan	25
13	Mapping each pre-existing condition’s association to short-term and long-term COVID-19 complications 2021 ·npj Digital Medicine ·AJ Venkatakrishnan,Colin Pawlowski,David Zemmour,(unknown),Akash Anand,(unknown),(unknown),Arjun Puranik,(unknown),Sairam Bade,Rakesh Barve,(unknown),John C. O’Horo,Andrew D. Badley,John Halamka,Venky Soundararajan	18
14	Healthcare disparities among anticoagulation therapies for severe COVID‐19 patients in the multi‐site VIRUS registry 2021 ·Journal of Medical Virology ·(unknown),Colin Pawlowski,Arjun Puranik,(unknown),John C. O’Horo,Dina Gomaa,Valerie Banner‐Goodspeed,Jarrod Mosier,И. Б. Заболотских,(unknown),Michael Bernstein,Howard A. Zaren,Vikas Bansal,(unknown),Andrew D. Badley,Rahul Kashyap,AJ Venkatakrishnan,Venky Soundararajan	7
15	Casirivimab-Imdevimab Treatment Is Associated with Reduced Rates of Hospitalization Among High-Risk Patients with Mild to Moderate Coronavirus Disease-19 2021 ·SSRN Electronic Journal ·Raymund R. Razonable,Colin Pawlowski,John C. O’Horo,Lori L. Arndt,Richard Arndt,Dennis M. Bierle,(unknown),Sara N. Hanson,(unknown),Patrick J. Lenehan,Arjun Puranik,Leigh L. Speicher,Maria Teresa Seville,Sidna M. Tulledge‐Scheitel,AJ Venkatakrishnan,Caroline G. Wilker,Andrew D. Badley,Ravindra Ganesh	6
16	Pre-existing conditions are associated with COVID-19 patients’ hospitalization, despite confirmed clearance of SARS-CoV-2 virus 2021 ·EClinicalMedicine ·Colin Pawlowski,AJ Venkatakrishnan,(unknown),(unknown),Arjun Puranik,(unknown),(unknown),Akash Anand,Rakesh Barve,John C. O’Horo,Andrew D. Badley,Venky Soundararajan	12
17	Inference from longitudinal laboratory tests characterizes temporal evolution of COVID-19-associated coagulopathy (CAC) 2020 ·eLife ·Colin Pawlowski,(unknown),Arjun Puranik,(unknown),(unknown),AJ Venkatakrishnan,Rajiv K. Pruthi,Damon E. Houghton,John C. O’Horo,William G. Morice,Amy W. Williams,Gregory J. Gores,John Halamka,Andrew D. Badley,Elliot S. Barnathan,Hideo Makimura,Najat Khan,Venky Soundararajan	23
18	Robust Classification 2018 ·Dimitris Bertsimas,Jack Dunn,Colin Pawlowski,Ying Daisy Zhuo	38
19	From predictive methods to missing data imputation: an optimization approach 2017 ·Journal of Machine Learning Research ·Dimitris Bertsimas,Colin Pawlowski,Ying Daisy Zhuo	140
20	DOUBLE‐BLIND STUDY COMPARING THE LONG‐TERM EFFICACY OF THE COX‐2 INHIBITOR NIMESULIDE AND NAPROXEN IN PATIENTS WITH OSTEOARTHRITIS 2001 ·International Journal of Clinical Practice ·(unknown),(unknown),(unknown),(unknown),A. Macciocchi,(unknown),Colin Pawlowski	25

About Colin Pawlowski

Colin Pawlowski is a scholar working on Computational Mathematics, Infectious Diseases and Health, having authored 30 papers that have together received 857 indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (15 papers), COVID-19 Clinical Research Studies (13 papers) and Vaccine Coverage and Hesitancy (7 papers). The work is most often cited by research in Infectious Diseases (469 citations), Health (165 citations) and Modeling and Simulation (71 citations). Colin Pawlowski has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Dimitris Bertsimas, Ying Daisy Zhuo, John C. O’Horo, Andrew D. Badley, Venky Soundararajan, AJ Venkatakrishnan, Arjun Puranik, Patrick J. Lenehan, John Halamka and Melanie D. Swift. Their work appears in journals such as Circulation, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact